5 News & Press Releases found
Atelerix Ltd News
-
Atelerix presents promising data for the application of its technology LeukoStor™ to Monocyte Preservation
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched blood ...
-
New distributor agreement between Atelerix and BioBench Solutions LLP
New distributor agreement between Atelerix (UK) and BioBench Solutions LLP (India). We are proud to announce the beginning of a new distribution agreement with BioBench Solutions, who will be distributing our products across Indian. Our global ...
-
New patent application published!
Atelerix has received notification that its newest patent application has been published pertaining to the STORING AND/OR TRANSPORTING OF EXTRACELLULAR NUCLEIC ACIDS (WO 2022/101640). This application was made after the surprising observation that ...
-
Atelerix appoints new CEO to lead its growing business and entry into cell therapy markets
Atelerix Ltd (Atelerix) announces the appointment of a new CEO as the company accelerates its growth programme. Over the last four years, the company has been led by co-founder and CEO, Mick McLean, as it developed its products and started ...
-
CELLINK and Atelerix team up to enable the shipping at room temperature of fragile 3D bioprinted constructs by the world’s bioprinting community
CELLINK and Atelerix announced today a partnership to bring to market Atelerix’s portfolio of innovative hydrogel biological encapsulation products, which preserve fragile biological samples for shipping at room temperature. ...